It has demonstrated the ability to downregulate antiapoptotic proteins such as Mcl-1, Bcr-Abl and JAK2, resulting in the apoptosis of myeloid and lymphoid tumor cells, but as time goes by, the inhibitory of MCL-1 has weakened [108]. This evidence concerns the gene MCL1 and lymphoid neoplasm.